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Integrative Clustering of Multiple Genomic
Data Types using a Joint Latent Variable
Model with Application to Breast and Lung
Cancer Subtype Analysis
Ronglai Shen, Adam Olshen, and Marc Ladanyi

Abstract

The molecular complexity of a tumor manifests itself at the genomic, epigenomic, transcriptomic, and proteomic levels. Genomic profiling at these multiple levels should allow an integrated characterization of tumor etiology. However, there is a shortage of effective statistical and bioinformatic tools for truly
integrative data analysis. The standard approach to integrative clustering is separate clustering followed by manual integration. A more statistically powerful
approach would incorporate all data types simultaneously and generate a single integrated cluster assignment. We developed a joint latent variable model
for integrative clustering. We call the resulting methodology iCluster. iCluster
incorporates flexible modeling of the associations between different data types
and the variance-covariance structure within data types in a single framework,
while simultaneously reducing the dimensionality of the data sets. Likelihoodbased inference is obtained through the Expectation-Maximization algorithm. We
demonstrate the iCluster algorithm using two examples of joint analysis of copy
number and gene expression data, one from breast cancer and one from lung cancer. In both cases, we identified subtypes characterized by concordant DNA copy
number changes and gene expression as well as unique profiles specific to one
or the other in a completely automated fashion. In addition, the algorithm discovers potentially novel subtypes by combining weak yet consistent alteration
patterns across data types. R code to implement iCluster can be downloaded at
http://www.mskcc.org/mskcc/html/85130.cfm.
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Abstract
The molecular complexity of a tumor manifests itself at the genomic, epigenomic,
transcriptomic, and proteomic levels. Genomic profiling at these multiple levels should
allow an integrated characterization of tumor etiology. However, there is a shortage
of effective statistical and bioinformatic tools for truly integrative data analysis. The
standard approach to integrative clustering is separate clustering followed by manual
integration. A more statistically powerful approach would incorporate all data types
simultaneously and generate a single integrated cluster assignment. We developed a
joint latent variable model for integrative clustering. We call the resulting methodology
iCluster. iCluster incorporates flexible modeling of the associations between different
data types and the variance-covariance structure within data types in a single framework, while simultaneously reducing the dimensionality of the data sets. Likelihoodbased inference is obtained through the Expectation-Maximization algorithm. We
demonstrate the iCluster algorithm using two examples of joint analysis of copy number and gene expression data, one from breast cancer and one from lung cancer. In both
cases, we identified subtypes characterized by concordant DNA copy number changes
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and gene expression as well as unique profiles specific to one or the other in a completely
automated fashion. In addition, the algorithm discovers potentially novel subtypes by
combining weak yet consistent alteration patterns across data types. R code to implement iCluster can be downloaded at http://www.mskcc.org/mskcc/html/85130.cfm.
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Introduction

In recent years genomic profiling of multiple data types in the same set of tumors has gained
prominence. In a breast cancer study relating DNA copy number to gene expression, Pollack et al. (2002) estimated that 62% of highly amplified genes demonstrate moderately or
highly elevated gene expression, and that DNA copy number aberrations account for about
10-12% of the global gene expression changes at the messenger RNA (mRNA) level. Hyman
et al. (2002) observed similar results in breast cancer cell lines. MicroRNAs, which are small
noncoding RNAs that repress gene expression by binding mRNA target transcripts, provide
another mechanism of gene expression regulation. Over 1000 microRNAs are predicted to
exist in humans, and they are estimated to target one-third of all genes in the genome (Lewis
et al., 2005). The NCI/NHGRI-sponsored Cancer Genome Atlas (TCGA) pilot project is a
coordinated effort to explore the entire spectrum of genomic alternations in human cancer
to obtain an integrated view of such interplays. The group recently published an interim
analysis of DNA sequencing, copy number, gene expression and DNA methylation data in a
large set of glioblastomas (TCGA, 2008).
In this study, we will refer to any genomic data set involving more than one data type
measured in the same set of tumors as multiple genomic platform (MGP) data. Identifying tumor subtypes by simultaneously analyzing MGP data is a new problem. The current
approach to subtype discovery across multiple types is to separately cluster each type and
then to manually integrate the results. An ideal integrative clustering approach would allow
joint inference from MGP data and generate a single integrated cluster assignment through
simultaneously capturing patterns of genomic alterations that are: 1) consistent across multiple data types; 2) specific to individual data types; or 3) weak yet consistent across data
sets that would emerge only as a result of combining levels of evidence. Therefore, the goal
of this study is to develop such an integrative framework for tumor subtype discovery.
There are two major challenges to the development of a truly integrative approach. First,
to capture both concordant and unique alterations across data types, separate modeling of
the covariance between data types and the variance-covariance structure within data types
is needed. Most of the existing deterministic clustering methods cannot be easily adapted
in this way. For example, Qin (2008) performed a hierarchical clustering of the correlation
matrix between gene expression and microRNA data. Similarly, Lee et al. (2008) applied a
biclustering algorithm on the correlation matrix to integrate DNA copy number and gene expression data. In both cases, the goal was to identify correlated patterns of change given the
two data types. While identifying correlated patterns is sufficient for studying the regulatory
3
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mechanism of gene expression via copy number changes or epi-genomic modifications, it is
not suitable for integrative tumor subtype analysis where both concordant and unique alteration patterns may be important in defining disease subgroups. This will be demonstrated
in our data examples. In addition, properly separating covariance between data types and
variance within data types facilitates probabilistic inference for data integration.
Second, dimension reduction is key to the feasibility and performance of integrative clustering approaches. Methods that rely on pairwise correlation matrices are computationally
prohibitive with today’s high resolution arrays. Dimension reduction techniques such as
principal component analysis (PCA) (Alter et al., 2000; Holter et al., 2000) and nonnegative
matrix factorization (NMF) (Brunet et al., 2004) have been proposed for use in combination with clustering algorithms. These methods work well for a single data type. However,
simultaneous dimension reduction of multiple correlated data sets is beyond the capabilities
of these algorithms.
Tipping and Bishop (1999) showed that principal components can be computed through
maximum-likelihood estimation of parameters under a Gaussian latent variable model. In
their framework, the correlations among variables are modeled through the latent variables
of a substantially lower dimension space while an additional error term is added to model
the residual variance. Using this as a building block, we propose a novel integrative clustering method called iCluster that is based on a joint latent variable model. The main
idea behind iCluster is that tumor subtypes can be modeled as unobserved (latent) variables
that can be simultaneously estimated from copy number data, mRNA expression data, and
other available data types. It is a conceptually simple and computationally feasible model
that allows simultaneous inference on any number and type of genomic data sets. Furthermore, we develop a sparse solution of the iCluster model through optimizing a penalized
complete-data log-likelihood using the EM algorithm (Dempster et al., 1977). A lasso-type
regularization method (Tibshirani , 1996) is used in the penalized complete-data likelihood.
The resulting model continuously shrink the coefficients for non-informative genes toward
zero, and thus leading to reduced variance and better clustering performance. Moreover, a
variable selection strategy emerges (since the coefficients for some of the genes will be exactly
zero under lasso penalty), which helps pinpoint important genes.
The paper is organized as follows. In Section 2.1, we discuss the K-means clustering
algorithm and a global optimal solution for the K-means problem through PCA. In Section
2.2, we formulate the K-means problem as a Gaussian latent variable model and show the
maximum likelihood-based solution and its connection with the PCA solution. Then in
Section 2.3, we extend the latent variable model to allow multiple data types for the purpose
of integrative clustering. A sparse solution is derived in Section 2.4. We demonstrate the
method using two data sets from published studies in the Results Section.

4
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2
2.1

Methods
Eigengene K-means Algorithm

We start the investigation with the K-means clustering algorithm. In standard K-means,
given an initial set of K cluster assignments and the corresponding cluster centers, the
procedure iteratively moves the centers to minimize the total within-cluster variance. For
purposes of exposition, we assume the data are gene expression, although they could be
any type of genomic measurements. Let X denote the mean-centered expression data of
dimension p × n with rows being genes and columns being samples. Given a partition C
of the column space of X and the corresponding cluster mean vectors {m1 , · · · , mK }, the
sample vectors X = {x1 , · · · , xn } are assigned cluster membership such that the sum of
within-cluster squared distances is minimized:
min

K
X
X

k=1 C(i)=k

kxi − mk k2 .

(1)

The cluster centers are subsequently recalculated successively based on the current partition.
The algorithm iterates until the assignments do not change.
One of the main criticisms of K-means clustering is that the algorithm is sensitive to the
choice of starting points; it can iterate to local minima rather than the global maximum.
However, it has been recently shown that a better optimization scheme for K-means arises
through principal component analysis (Zha et al., 2001). To see this, let Z = (z1 , · · · , zK )′
with the kth row being the indicator vector of cluster k normalized to have unit length:
1
1
z′k = (0, · · · , 0, √ , · · · √ , 0, · · · , 0),
nk
nk
{z
}
|

(2)

nk

P
where nk is the number of samples in cluster k and K
k=1 nk = n. The objective is to obtain
an optimal solution of the cluster assignment matrix Z such that the within-cluster variance
is minimized. Let X′ X be the Gram matrix of the samples. The K-means loss function in
(1) can be expressed as
trace(X′ X) − trace(ZX′ XZ′ ),
which is the total variance minus the between-cluster variance. Since the total variance is
a constant given the data, it follows that minimizing (1) is equivalent to maximizing the
between-cluster variance
max
trace(ZX′ XZ′ ).
(3)
′
ZZ =IK

Now consider a continuous Z∗ that satisfies all the conditions of Z except for the discrete
structure. In other words, z∗k is no longer restricted to take values of either zero or one (scaled
5
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by the square-root of the cluster size). Then the above is equivalent to the eigenvalue decomposition of S. Therefore a closed-form solution of (3) is Ẑ∗ = E, where E = (e1 , · · · , eK )′ are
the eigenvectors corresponding to the K largest eigenvalues from the eigenvalue decomposition of S. As a result, Ẑ∗ is the solution to the relaxed trace maximization problem of (3).
A later publication by Ding and He (2004) pointed out the redundancy in Z such that the
K-means solution can be defined by the first K − 1 eigenvectors. The eigenvectors lie in a
low-dimensional latent space where the original data are projected onto each of the first K −1
principal directions such that the total variance is maximized. As a result, any distinct subgroup structures will be automatically embedded in this set of orthogonal directional vectors.
Note that although the continuous parameterization of Z causes some loss in interpretability of the cluster indicator matrix, it is a necessary condition for the closed-form optimal
solution to the K-means problem. The discrete structure in Z and its interpretability can be
easily restored by a simple mapping by a pivoted QR decomposition or a standard K-means
algorithm invoked on Z∗ . Zha et al. (2001) found similar performance by the two methods
for recovering the class indicator matrix. For simplicity, in what comes later we use K-means
for this final step. Finally, since we are in the genomic data context, we refer to the algorithm
described in this section as eigengene K-means, and it yields the eigengene solution ẐE .

2.2

A Gaussian Latent Variable Model Representation

Now we consider a Gaussian latent variable model representation of the eigengene K-means
clustering:
X = WZ + ε,
(4)
where X is the mean-centered expression matrix of dimension p × n (no intercept), Z =
(z1 , · · · , zK−1 )′ is the cluster indicator matrix of dimension (K − 1) × n as defined in Section
2.1, W is the coefficient matrix of dimension p × (K − 1), and ε=(ε1 , · · · , εp )′ is a set of
independent error terms with zero mean and a diagonal covariance matrix Cov(ε) = Ψ
where Ψ = diag(ψ1 , · · · , ψp ). The fundamental concepts of model (4) are: 1) it differs from
a regular regression model in that (z1 , · · · , zK−1 ) are treated as latent variables representing
the true molecular tumor subtypes to be discovered; and 2) in dimension reduction terms,
W is the projection matrix that maps the gene×array space of the original data matrix X
onto an eigengene×eigenarray subspace spanned by the first K − 1 principal directions.
Now consider a continuous parameterization Z∗ of Z and make the additional assumption
that Z∗ ∼ N (0, I) and ε ∼ N (0, Ψ). Then a likelihood-based solution to the K-means
problem is available through model (4). The inference will be based on the posterior mean of
Z∗ given the data. Tipping and Bishop (1999) established a connection between the Gaussian
latent variable model and PCA under an isotropic error model with a scalar covariance matrix
Ψ = σ 2 I. Then it was shown that by plugging in the maximum likelihood estimate of W
and σ 2 , the posterior mean is represented through the principal axes of the data vectors. In
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particular,
Ê[Z∗ |X] = (Λ − σ 2 I)1/2 Λ−1/2 E,

(5)

where E denotes the eigengene matrix as defined before. It is clear the posterior mean yields
the same eigengene K-means solution Ẑ∗ = E if the residual error σ 2 is assigned the value
zero. However, the subspace Ê[Z∗ |X] obtained through maximum likelihood approach will
not generally correspond to the principal subspace obtained through PCA. Such a link occurs
only under the isotropic error model.
The motivation for formulating the K-means problem as a Gaussian latent variable model
is two-fold: 1) it provides a probabilistic inference framework; and 2) the latent variable
model has a natural extension to multiple data types. In the next section, we propose a
joint latent variable model for integrative clustering.

2.3

iCluster: A Joint Latent Variable Model-Based Clustering
Method

The basic concept of iCluster is to jointly estimate Z = (z1 , · · · , zK−1 )′ , the latent tumor
subtypes, from, say, DNA copy number data (denoted by X1 , a matrix of dimension p1 × n),
DNA methylation data (denoted by X2 , a matrix of dimension p2 ×n), mRNA expression data
(denoted by X3 , a matrix of dimension p3 × n), and so forth (Figure 1). The mathematical
form of the integrative model is
X1 = W1 Z + ε1
X2 = W2 Z + ε2
..
.
Xm = WmZ + εm,

(6)

where m is the number of genomic data types available for the same set of samples. We
assume each data set is row centered and therefore intercept terms are not included in the
models. In (6), Z is the latent component that connects the m-set of models, inducing deDNA Copy
Number Data
X1

mRNA Expression
Data
X3

Epigene!c Data incl.
DNA Methyla!on

X2

MicroRNA
Expression Data
X4

Tumor Subtypes
Z

Figure 1: The integrative model. The concept is to formulate the tumor subtypes as the
joint latent variable Z that needs to be simultaneously estimated from multiple genomic
data types measured on the same set of tumors.
7
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pendencies across the data types measured on the same set of tumors. On the other hand,
the independent error terms (ε1 , · · · , εm), in which each has mean zero and diagonal covariance matrix Ψi , represent the remaining variances unique to each data type after accounting
for the correlation across data types. Lastly, (W1 , · · · , Wm ) denote the coefficient matrices.
In dimension reduction terms, they embed a simultaneous data projection mechanism that
maximizes the correlation between data types.
To derive a likelihood-based solution of (6), we use a latent continuous parameterization
that further assumes Z∗ ∼ N (0, I). The error term is ε ∼ N (0, Ψ), which has a diagonal
covariance matrix Ψ = diag(ψ1 , · · · , ψPi pi ). The marginal distribution of the integrated
data matrix X = (X1 , · · · , Xm )′ is then multivariate normal with mean zero and covariance
matrix Σ = WW′ + Ψ, where W = (W1 , · · · , Wm )′ . The corresponding log-likelihood
function of the data is
!
m
n X
ℓ(W, Σ) = −
pi ln(2π) + ln det(Σ) + tr(Σ−1 G) ,
(7)
2 i=1
where G is the sample covariance matrix of the

G11 G12
 G21 G22

G =  ..
..
 .
.
Gm1 Gm2

following form

· · · G1m
· · · G2m 

..  .
...
. 
· · · Gmm

(8)

We employ the EM algorithm to obtain the maximum likelihood estimates of W and Ψ.
In the EM framework, we deal with the complete-data log-likelihood
m
o
nn X
pi ln(2π) + ln det(Ψ)
ℓc (W,Ψ) = −
2 i=1
(9)
n
o
1
∗ ′ −1
∗
∗′ ∗
tr((X − WZ ) Ψ (X − WZ )) + tr(Z Z ) .
−
2
This is a much more efficient approach than directly maximizing the marginal data likelihood
in (7). It does not require
P 2 explicit evaluation of the sample covariance matrices in (8), which
would call for O(n i pi ) operations and thus be computationally prohibitive.

Finally, the problem of p >> n is exacerbated in our model by the multiple highdimensional data sets. A sparse solution to W is desirable. In the next Section, we derive a
sparse solution to solve the iCluster model via penalizing the complete-data log-likelihood.

2.4

A Sparse Solution

We write the penalized complete data log-likelihood as
ℓc,p (W, Ψ) = ℓc (W, Ψ) − Jλ (W),

(10)

8
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where Jλ (W) is a penalty term on W with a nonnegative regularization parameter λ. Various
types of penalties can be employed. In this study, we use a lasso type (L1 -norm) penalty
(Tibshirani , 1996) that takes the form
Jλ (W) = λ

pi
m K−1
X
XX
i=1 k=1 j=1

|wikj | .

(11)

We derive the E-step and the M-step with respect to the penalized complete-data loglikelihood. The E-step involves computing the objective function
Qp (W, Ψ|W(t) , Ψ(t) ) = EZ∗ |X,W(t) ,Ψ(t) [ℓc,p (W, Ψ)],
which is the expected value of the complete-data log-likelihood with respect to the distribution of Z∗ given X under the current estimates (W(t) , Ψ(t) ). This involves computing the
following quantities given the current parameter estimates:
E[Z∗ |X] = W′ Σ−1 X and
′
E[Z∗ Z∗ |X] = I − W′ Σ−1 W + E[Z∗ |X]E[Z∗ |X]′ .

(12)

The E-step provides a simultaneous dimension reduction by mapping the original data matrices of joint dimensions (p1 , · · · , pm ) × n to a substantially reduced subspace represented
by Z∗ of dimension (K − 1) × n.
The M-step is to update the parameter estimates by maximizing Qp subject to kwk k = 1
for all k. This leads to the following estimate of Ψ:

1
Ψ(t+1) = diag XX′ − W(t) E[Z∗ |X]X′
(13)
n
and the lasso estimate of W:

(t+1)
Wlasso = sign(W(t+1) ) |W(t+1) | − λ + ,
(14)
′

where W(t+1) = (XE[Z∗ |X]′ ) (E[Z∗ Z∗ |X])−1 . This is followed by a normalization step
wk /kwk k2 for all k, where kwk k2 denotes the L2 norm of the vector wk that takes the form
q
P 2
j wjk . The algorithm iterates between the E-step and the M-step until convergence.

Once Ê[Z∗ |X] is obtained, a final step to recover the class indicator matrix is to invoke a
standard K-means on Ê[Z∗ |X]. We denote this solution as ẐiCluster .
The lasso-type penalty results in sparse estimates of W in which many of the coefficients
are shrunken toward zero. The variance of the model is thus reduced, leading to better
clustering performance though the bias-variance trade-off. The lasso also renders a variable
selection mechanism owing to the L1 penalty that shrinks some coefficients to exactly zero.
As a result, one can pinpoint which genes contribute to which subtype by finding the genes
with non-zero loadings on the k th latent factor zk . This will be demonstrated in the data
example.
9
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2.5

Model Selection Based on Cluster Separability

Let B̂∗ = Ê[Z∗ |X]′ Ê[Z∗ |X] be ordered such that samples belonging to the same clusters
are adjacent. Then B̂∗ has a diagonal block structure and p
can be used to assess cluster
separability. We standardize the elements of B̂∗ to be bij / bii bjj for i = 1, · · · , n and
j = 1, · · · , n, and impose a non-negative constraint by setting negative values to zero. Then
perfect cluster separability (non-overlapping subclasses) would lead to an exact diagonal
block matrix with diagonal blocks of ones for samples belonging to the same cluster and offdiagonal blocks of zeros for samples in different clusters. As cluster separability decreases, B̂∗
increasingly deviates from the “perfect” diagonal block structure. We thus define a deviance
measure d as the sum of absolute differences between B̂∗ and a “perfect” diagonal block
matrices of 1s and 0s. The proportion of deviance is defined as POD=d/n2 so that POD is
between 0 and 1. Small values of POD indicate strong cluster separability, and large values
of POD indicate poor cluster separability. In the data examples, we show the utility of B̂∗
matrix plots (we call them cluster separability plots) and associated the POD statistic for
model selection, which includes estimating the number of clusters K and the lasso parameter
λ.

3
3.1

Results
Subtype Discovery in Breast Cancer

Pollack et al. (2002) studied 37 primary breast cancers and 4 breast cancer cell lines for
DNA copy number and mRNA expression on the same cDNA microarrays that contain 6,691
genes. Figure 2A shows the pair of heatmaps displaying the alteration patterns in the DNA
(left panel) and in the mRNA (right panel) on chromosome 17. Samples are arranged by
separate hierarchical clustering output. Clearly the two dendrograms are substantially different. Although the leftmost clusters share members that carry the HER2/ERBB2 amplicon
profile near 17q12, they are not identical. This is a problem inherent to separate clustering
approaches that fail to account for the correlation between the two data sets. On the other
hand, mixing breast tumors and cell line samples, the four cell line samples (BT474, T47D,
MCF7, and SKBR3, indicated in red text) should be distinguished as a separate “subtype”
from the rest of the tumor samples. This is clearly the case in the gene expression data, but
it is not recapitulated in the DNA copy number data. This contrast shows the importance
of capturing unique patterns specific to one data type.
Figure 2B-E show results of a unified set of cluster assignments from iCluster on the same
data. Non-sparse (λ = 0) and sparse solutions (λ = 0.01 and 0.2) were generated. Figure
2B includes cluster separability plots described in Section 2.3 under the sparse solution
given λ = 0.2. Clearly, K = 4 gives the best diagonal block structure. This is confirmed
in Figure 2C where the 4-cluster sparse solution (λ = 0.2) minimized the POD statistic
among a range of K and λ values. Figure 2D displays the heatmaps of the same data used
10
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Figure 2: Results from separate clustering (left panel) and integrative clustering (right panel)
using the Pollack data. A. Heatmaps of copy number (DNA) and gene expression (mRNA)
on chromosome 17. Samples are arranged by separate hierarchical clustering on each data
type. B. Cluster separability plots. C. Model selection based on POD measure. A 4-cluster
sparse solution (λ = 0.2) was chosen. D. Heatmaps on the same data as in A with samples
arranged by the integrated cluster assignment under the sparse iCluster model. E. KaplanMeier plots of the subclasses identified via the integrative clustering. The HER2/ERBB2
subtype showed poor survival.
in Figure 2A but with samples rearranged by their iCluster membership. In a completely
automated fashion, the 4 cell lines were separated as cluster 1 (red). The HER2/ERBB2
subtype emerged as Cluster 2 (green) and showed coordinated amplification in the DNA and
overexpression in the mRNA. This subtype was associated with poor survival as shown in
Figure 2E. Cluster 3 was a potentially novel subtype derived only as a result of combining
evidence across the two data sets. It represents a subset of tumors characterized by weak
yet consistent amplifications toward the end of the q-arm of chromosome 17. Finally, cluster
4 did not show any distinct patterns, though a pattern may have emerged if there were
additional data types. As mentioned in Section 2.4, the lasso-type penalty in the sparse
iCluster solution renders variable selection as part of the outcome. Supplementary Table 1
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lists the selected subset of genes associated with each of the subtypes.

3.2

Lung Cancer Subtypes Jointly Defined by Copy Number and
Gene Expression Data

We also analyzed a set of 91 lung adenocarcinomas from Memorial Sloan-Kettering Cancer
Center, which is a subset of the samples in Chitale et al. (2009). The iCluster method was
applied to perform integrative clustering on copy number and gene expression data. The
copy number data were segmented using the CBS algorithm (Olshen et al., 2004; Venkatraman et al., 2007). The segment means were used as the input for integration to reduce the
noise level. Variance filtering based on gene expression was performed so as to focus on the
most variable set of 2,782 genes.
Using chromosomes 8 and 12 as examples, we compared the iCluster results with those
obtained by separate hierarchical clustering. Cluster 1 in Figure 3A is characterized by a
broad region of 8p loss evident in the copy number heatmap and the corresponding underexpression in the expression heatmap. In contrast, this 8-p loss cluster is less well defined by
separate clustering in Figure 3B. When annotated with somatic mutation status, this cluster
shows significant enrichment of EGFR mutations (mutation panel on top of the heatmap).
Specifically, 33% of the tumors in cluster 1 carry EGFR mutation, while 16%, 0%, and 18%
of the tumors in cluster 2, 3, and 4 respectively, are EGFR mutant samples (Fisher’s exact
test P=0.03). Another interesting observation made apparent by iCluster is that samples
in cluster 4 show a similar but somewhat diluted pattern of copy number aberrations when
compared to cluster 1. These samples may be related to cluster 1 but with lower tumor
content, which may account for the 18% EGFR mutations in this cluster, the second highest
among the four clusters. Chitale et al. (2009) describe the association between chromosome
8p loss and EGFR mutation in further details. When studying the genes within the broad
region of 8p loss, they discovered a striking association between EGFR mutation and concordant DUSP4 deletion and underexpression. DUSP4 is known to be involved in negative
feedback control of EGFR signaling. Notably, the sparse solutions consistently showed better cluster separability than the non-sparse solution as evidenced by Figure 3C.
Chromosome 12 is another interesting example. Cluster 2 in Figure 3D is characterized
by the well-known 12q14-15 amplicon that includes oncogenes such as CDK4 and MDM2.
Again, the sparse solution improves the cluster separability substantially from the nonsparse solution (Figure 3F). Interestingly, the sparse model selected only 24 DNA probes
that contributed to the clustering, which is consistent with the observation that there are
relatively few aberrations other than the small region of 12q gain in the DNA. Note, however,
that genomic alteration patterns are often chromosome-specific (8p-loss and 12q-gain); They
do not always occur in the same set of patients. Therefore, the results change when multiple
chromosomes are combined (see Supplementary Figure 1).
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Figure 3: Lung cancer subtypes for chromosome 8 and 12. A. Heatmap of DNA copy number
(left) and mRNA expression (right) on chromosome 8. Columns are tumors arranged by the
3 subclasses obtained by iCluster. Rows are genes ordered by genomic position. On top
of the heatmaps are gray-dot panels indicating mutation status of several well-known lung
cancer genes. B. Separate hierarchical clustering of the same data on chromosome 8 used in
A. C. Model selection based on the POD measure. A 4-cluster sparse solution (λ = 0.05)
was chosen that selected 301 mRNA probes and 126 DNA probes from a total of 642 probes.
D. iCluster output on chromosome 12. Tumor samples are arranged by the 6 subclasses
obtained by iCluster. E. Separate hierarchical clustering of the same data on chromosome
12 used in D. F. Model selection based on the POD statistic. A 6-cluster sparse solution
(λ = 0.1) was chosen that selected 408 mRNA probes and 24 DNA probes from a total of
1038 probes.

4

Discussion

Despite the ever-increasing volume of multiple genomic platform (MGP) data resulting from
the Cancer Genome Atlas project and other studies, there is a shortage of effective integrative methods. Researchers often resort to heuristic approaches where “manual integration”
is performed after separate analysis of individual data types, and it is unlikely two investigators would perform manual integration in the same manner. Manual integration may
require a considerable amount of prior knowledge about the underlying disease. In contrast,
13
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the iCluster method developed here generates a single integrated cluster assignment based
on simultaneous inference from multiple data types. In both the breast and lung cancer data
examples, we have shown that iCluster aligns concordant DNA copy number aberrations and
gene expression changes. In some cases, potentially novel subclasses are revealed only by
combining weak yet consistent evidence across data types.
In this study, we applied iCluster to integrate copy number and gene expression data.
The joint latent variable model is completely scalable to include additional data types. Nextgeneration sequencing is emerging as an appealing alternative to microarrays for inferring
RNA expression levels (mRNA-Seq), DNA-protein interactions (ChIP-Seq), DNA methylation, and so on. Although we focus here on array data, our integrative framework could
be generalized to next-gen sequencing data after proper modifications of the error terms to
model count data based on mapped reads.
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